Skip to main content
Quest Diagnostics

Long Non-coding RNA Signatures to Distinguish Relapsing-Remitting and Progression Forms of Multiple Sclerosis

The European Committee for Treatment and Research in Multiple Sclerosis, 9th joint ECTRIMS-ACTRIMS meetings

ECTRIM 2023

Milan, Italy Oct 11-13, 2023

Poster presentation: Long Non-coding RNA Signatures to Distinguish Relapsing-Remitting and Progression Forms of Multiple Sclerosis

Authors: Sesler CL, Wylezinski LS, Shaginurova GI, Grigorenko EV, Cockerill, FR III, Racke MK, Spurlock, CF III

Specialty: Neurology

Reated content

Publication
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings
Publication
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
Publication
Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.